FDA.reportPublic FDA data

Fluzone Quadrivalent 2025-2026 vaccine Injectable Suspension

RxCUI
2719474
RxNorm name
Fluzone Quadrivalent 2025-2026 vaccine Injectable Suspension
Display name
Fluzone Quadrivalent 2025-2026 vaccine Injectable Suspension
Full name
Fluzone Quadrivalent 2025-2026 vaccine Injectable Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8213c229-a67a-4d3f-bd8f-b8729ae28472Fluzone Quadrivalent 2025-2026 vaccine Injectable Suspension [PSN] · influenza A virus A/Croatia/10136RV/2023 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/4897/2022 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Michigan/01/2021 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Injectable Suspension [Fluzone Quadrivalent 2025-2026] [SBD] · Fluzone Quadrivalent 2025-2026 vaccine Injectable Suspension [SY]325These highlights do not include all the information needed to use Fluzone ® Quadrivalent safely and effectively. See full prescribing information for Fluzone Quadrivalent. Fluzone Quadrivalent (Influenza Vaccine) injectable suspension, for intramuscular use 2025-2026 Formula Initial U.S. Approval: 201320250711